Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pressure BioSciences Inc. PBIO

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Conversion of Additional $7.24M of Debt into Equity

Posted on June 12, 2018 by MissionIR

Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced the conversion of an additional $7.24 million of debt into equity, bringing the total amount of debt that has converted into equity over the past four weeks to … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Boosts Drug Development Process through Acquisition of PreEMT™ Platform

Posted on June 1, 2018 by MissionIR

Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently acquired the PreEMT™ platform to develop a unique manufacturing method and improve the quality of a key protein-based drug being developed. A recent article discussing the company reads: “The acquisition of … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Pressure BioSciences Inc.’s (PBIO) Recently Acquired PreEMT™ Platform Enhances Development of Biotherapeutic Protein Drugs

Posted on May 30, 2018 by MissionIR

Biologics offer novel ways of treating degenerative diseases like Alzheimer’s Biologics are one of the fastest-growing drug categories PreEMT™ technology improves quality, reduces cost of biologic manufacture When we think of drugs, an image of potions in round-bottom flasks conjured … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Increase in Revenue, Debt Conversion in Q1 2018

Posted on May 25, 2018 by MissionIR

Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently announced financial results for the first quarter ended March 31, 2018. Among other highlights, the company reported first quarter revenue growth and debenture conversion. An article discussing the report further reads: … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Revenue Growth, Debt Conversion Boost Pressure BioSciences’ (PBIO) Outlook at Close of First Quarter

Posted on May 18, 2018 by MissionIR

High-pressure lab equipment maker reports ninth consecutive quarter of revenue growth (Y/Y) About 92 percent of debenture debt converted to preferred stock, with aim of uplisting to national stock exchange Patented technologies continue to drive optimism for company’s products to … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Q1 Financial Results, Provides Business Update; Schedules Earnings Call

Posted on May 15, 2018 by MissionIR

Global life sciences company Pressure BioSciences (OTCQB: PBIO) today announced financial results for the first quarter ended March 31, 2018. Among other highlights, Pressure BioSciences reported total revenue of $610,774 for the first quarter of 2018 compared to $551,357 for … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Agreement Related to Recently Acquired PreEMT™ Platform

Posted on May 3, 2018 by MissionIR

Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) today announced that it has signed an agreement with an international biopharmaceutical company to assess the potential of PBIO’s recently acquired PreEMT™ platform to develop a unique manufacturing process and improve … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO to Host Webinar on May 2

Posted on May 2, 2018 by MissionIR

Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced that Richard T. Schumacher, the company’s president and CEO, will be hosting a webinar update and live Q&A session for investors today at 3:00 pm EDT. Per the … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Sees 2018 as Year of Growth for BaroFold, Ultra Shear Technology Programs

Posted on April 13, 2018 by MissionIR

Pressure BioSciences (OTCQB: PBIO) recently announced newly-issued patents in Ultra Shear Technology (“UST”) that address broad markets for stable, water-soluble nanoemulsions, including cannabinoids. An article further discussing the company reads: “With the BaroFold acquisition and the new developments in Ultra … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Pressure BioSciences Inc.’s (PBIO) New Products and Enhanced Sales Capabilities Drive Plans for Banner 2018

Posted on April 10, 2018 by MissionIR

Record product sales growth reported for fourth quarter and full year 2017 Company has over 300 of its ultra-high pressure instruments in research labs worldwide 2017 revenue exceeded $2.2 million with just one field sales rep; company’s field sales force … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment